Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fundviser Capital has confirmed there is no deviation or variation in how it used the money raised from its November 2025 preferential issue of 64,85,000 convertible warrants. The company had received 25% of the total issue amount of Rs. 79.44 crore, which is Rs. 19.86 crore. Of this, Rs. 19.85 crore has already been used: Rs. 12.80 crore was invested in subsidiary DARS Transtrade Pvt Ltd, Rs. 62.05 lakh in New India Re & Infra LLP, Rs. 2 crore in Starlight Box Theatres Pvt Ltd, and Rs. 4.43 crore for general corporate purposes, working capital, and long-term funding needs. A small balance of Rs. 1.03 lakh remains unutilized. The Audit Committee reviewed the statement on 5th February 2026 and raised no objections.
For shareholders, this is a routine compliance filing confirming the company has used the warrant proceeds in line with what was disclosed. The heavy allocation to subsidiaries signals that growth is being routed through group companies, which investors should track for eventual returns.